drugset / Trial / NCT05178303

Composition for Treating Cirrhosis and Liver Cancer (SB-1121)

NCT05178303 ↗

Phase 4 Completed 134 enrolled Nguyen Thi Trieu, MD Tran Minh Duc · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The composition treats cirrhosis and hepatocellular carcinoma (Hcc) at an early stage. The product is extracted from herbs, including Adenosma glutinosum extract, Eclipta prostrata extract, Phyllanthus urinaria extract, Impatiens balsamina extract, Ascorbic acid, pyridoxine 5-phosphate, L-Arginine hydrochloride, Pregnenolone acetate. These components have participated in repairing and regenerating new liver parenchyma, preventing fibrosis cell generation, preventing liver cancer cell growth at an early stage. The composition supplements precursors which help the body strengthen antibodies and reduce the risk of inflammation, restore physiological and biochemical functions of liver cells after chronic inflammation.

Timeline

Start
2015-11-30
Primary completion
2021-10-10
Completion
2021-11-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject SB-1121(1) Traditional medicine (herbal / TCM) — —
Subject SB-1121(2) Traditional medicine (herbal / TCM) — —

Indications